Article
Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma
6 Jan 2020
Abstract excerpt
Drug resistance limits the therapeutic efficacy in cancers and leads to tumor recurrence through ill-defined mechanisms. Glioblastoma (GBM) are the deadliest brain tumors in adults. GBM, at diagnosis or after treatment, are resistant to temozolomide (TMZ), the standard chemotherapy. To better understand the acquisition of this resistance, we performed a longitudinal study, using a combination of mathematical...
Topics
Join the communities discussing this publication.